Protagenic Therapeutics Stock (NASDAQ:PTIX)
Previous Close
$3.26
52W Range
$2.35 - $15.54
50D Avg
$3.87
200D Avg
$5.40
Market Cap
$2.85M
Avg Vol (3M)
$1.94M
Beta
0.36
Div Yield
-
PTIX Company Profile
Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound is PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. The company is based in New York, New York.